Dr. Martens Plc (GB:DOCS)

Dr. Martens Plc (DOCS) Stock Price & Analysis


DOCS Stock Chart & Stats

Day’s Range0p - 0p
52-Week Range127.10p - 292.96p
Previous Close161.3p
Average Volume (3M)2.19M
Market Cap
Enterprise Value191.70B
Total Cash (Recent Filing)£133.00M
Total Debt (Recent Filing)£435.70M
Price to Earnings (P/E)9.1
Jun 01, 2023
0.06 (0.04%)
Share Statistics
EPS (TTM)0.18
Shares Outstanding1,000,557,598
10 Day Avg. Volume0
30 Day Avg. Volume2,190,966
Standard DeviationN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)1064.39
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside16.90% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering4




What was Dr. Martens Plc’s price range in the past 12 months?
Dr. Martens Plc lowest stock price was 127.10p and its highest was 292.96p in the past 12 months.
    What is Dr. Martens Plc’s market cap?
    Currently, no data Available
    When is Dr. Martens Plc’s upcoming earnings report date?
    Dr. Martens Plc’s upcoming earnings report date is Jun 01, 2023 which is in 3 days.
      How were Dr. Martens Plc’s earnings last quarter?
      Dr. Martens Plc released its earnings results on Nov 24, 2022. The company reported 0.045p earnings per share for the quarter, missing the consensus estimate of 0.047p by -0.002p.
        Is Dr. Martens Plc overvalued?
        According to Wall Street analysts Dr. Martens Plc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Dr. Martens Plc pay dividends?
          Dr. Martens Plc pays a Annually dividend of 1.56p which represents an annual dividend yield of 3.62%. See more information on Dr. Martens Plc dividends here
            What is Dr. Martens Plc’s EPS estimate?
            Dr. Martens Plc’s EPS estimate is £0.1.
              How many shares outstanding does Dr. Martens Plc have?
              Dr. Martens Plc has 1,000,816,200 shares outstanding.
                What happened to Dr. Martens Plc’s price movement after its last earnings report?
                Dr. Martens Plc reported an EPS of 0.045p in its last earnings report, missing expectations of 0.047p. Following the earnings report the stock price went down -22.697%.
                  Which hedge fund is a major shareholder of Dr. Martens Plc?
                  Currently, no hedge funds are holding shares in GB:DOCS


                  Dr. Martens Plc Stock Smart Score

                  The Dr. Martens Plc Holdings stock analysis is based on the TipRanks Smart Score which is derived from 6 unique data sets including Analyst recommendations, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Dr. Martens Plc

                  Dr. Martens PLC is engaged in the business of footwear. Its product segments include Originals, Fusion, Kids and Casual, and a complementary range of Accessories.


                  Top 5 ETFs holding DOCS

                  Market Value
                  Smart Score
                  dbxt FTSE ALL-S Shs -1D- Distribution
                  SPDR FTSE UK All Share UCITS ETF
                  SPDR UK All Sh Accum.Shs GBP
                  Lyxor Core UK Equity All Cap (DR) UCITS ETF
                  iShares MSCI UK IMI ESG Leaders UCITS ETF GBP
                  Up to five ETFs with an Outperform Smart Score that hold DOCS. The ETFs are listed according to market value of DOCS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  No data currently available

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis